| Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer (NCT01005329) | National Cancer Institute (NCI) | 2009-11-06 |
| Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer (NCT01012817) | National Cancer Institute (NCI) | 2009-11-03 |
| RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery (NCT01071564) | National Cancer Institute (NCI) | 2009-11-01 |
| Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma (NCT01012297) | National Cancer Institute (NCI) | 2009-11-01 |
| Selumetinib and Cixutumumab in Treating Patients With Advanced Solid Malignancies (NCT01061749) | National Cancer Institute (NCI) | 2009-11-01 |
| Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma (NCT01016015) | National Cancer Institute (NCI) | 2009-11-01 |
| Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer (NCT01038778) | National Cancer Institute (NCI) | 2009-10-29 |
| Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery (NCT01004978) | National Cancer Institute (NCI) | 2009-10-28 |
| Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT00989651) | National Cancer Institute (NCI) | 2009-10-28 |
| Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas (NCT01030900) | National Cancer Institute (NCI) | 2009-10-22 |
| Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms (NCT01005654) | National Cancer Institute (NCI) | 2009-10-07 |
| Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer (NCT01026623) | National Cancer Institute (NCI) | 2009-10-01 |
| Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors (NCT01017640) | National Cancer Institute (NCI) | 2009-10-01 |
| Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the Lung (NCT01013831) | National Cancer Institute (NCI) | 2009-10-01 |
| Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal Cancer (NCT00828984) | National Cancer Institute (NCI) | 2009-10-01 |
| Evaluation of Food Effect on Pharmacokinetics of Vismodegib (NCT01174264) | National Cancer Institute (NCI) | 2009-10-01 |
| A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors (NCT00994071) | National Cancer Institute (NCI) | 2009-09-22 |
| Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer (NCT00980460) | National Cancer Institute (NCI) | 2009-09-15 |
| Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer (NCT00977574) | National Cancer Institute (NCI) | 2009-09-14 |
| Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer (NCT01010126) | National Cancer Institute (NCI) | 2009-09-08 |
| Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer (NCT01064622) | National Cancer Institute (NCI) | 2009-09-03 |
| Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer (NCT01011933) | National Cancer Institute (NCI) | 2009-09-01 |
| Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer (NCT00986674) | National Cancer Institute (NCI) | 2009-09-01 |
| Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases (NCT00936975) | National Cancer Institute (NCI) | 2009-09-01 |
| Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia (NCT00792948) | National Cancer Institute (NCI) | 2009-09-01 |
| Dinaciclib in Treating Patients With Stage III-IV Melanoma (NCT01026324) | National Cancer Institute (NCI) | 2009-09-01 |
| Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer (NCT00982592) | National Cancer Institute (NCI) | 2009-09-01 |
| Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery (NCT00991952) | National Cancer Institute (NCI) | 2009-09-01 |
| A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC (NCT00963807) | National Cancer Institute (NCI) | 2009-09-01 |
| A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas (NCT00995007) | National Cancer Institute (NCI) | 2009-09-01 |
| National Cancer Institute Food Study (NCT00978406) | National Cancer Institute (NCI) | 2009-08-26 |
| Amplification of Merkel Cell Polyomavirus From Skin Swabs (NCT00977990) | National Cancer Institute (NCI) | 2009-08-25 |
| Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders (NCT00973804) | National Cancer Institute (NCI) | 2009-08-25 |
| MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00902577) | National Cancer Institute (NCI) | 2009-08-24 |
| Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer (NCT00983580) | National Cancer Institute (NCI) | 2009-08-20 |
| A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU) (NCT00978250) | National Cancer Institute (NCI) | 2009-08-20 |
| Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ (NCT00555152) | National Cancer Institute (NCI) | 2009-08-19 |
| Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (NCT00951496) | National Cancer Institute (NCI) | 2009-08-11 |
| Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer (NCT00937482) | National Cancer Institute (NCI) | 2009-08-01 |
| Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy (NCT00890747) | National Cancer Institute (NCI) | 2009-08-01 |
| Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy (NCT00965250) | National Cancer Institute (NCI) | 2009-08-01 |
| Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer (NCT01008566) | National Cancer Institute (NCI) | 2009-08-01 |
| Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma (NCT00994500) | National Cancer Institute (NCI) | 2009-08-01 |
| Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial (NCT00941655) | National Cancer Institute (NCI) | 2009-07-22 |
| Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery (NCT00861705) | National Cancer Institute (NCI) | 2009-07-21 |
| Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma (NCT00942877) | National Cancer Institute (NCI) | 2009-07-18 |
| A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer (NCT00942578) | National Cancer Institute (NCI) | 2009-07-16 |
| A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage (NCT00887159) | National Cancer Institute (NCI) | 2009-07-16 |
| Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer (NCT00942331) | National Cancer Institute (NCI) | 2009-07-15 |
| Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00731731) | National Cancer Institute (NCI) | 2009-07-10 |
| Human Papillomavirus Epidemiology in Nigeria (NCT00804466) | National Cancer Institute (NCI) | 2009-07-06 |
| A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area (NCT00913757) | National Cancer Institute (NCI) | 2009-07-01 |
| Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer (NCT00941070) | National Cancer Institute (NCI) | 2009-07-01 |
| FAU in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT00769288) | National Cancer Institute (NCI) | 2009-07-01 |
| R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer (NCT00666666) | National Cancer Institute (NCI) | 2009-07-01 |
| Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT00891072) | National Cancer Institute (NCI) | 2009-07-01 |
| Selumetinib in Cancers With BRAF Mutations (NCT00888134) | National Cancer Institute (NCI) | 2009-07-01 |
| Dinaciclib in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT01096342) | National Cancer Institute (NCI) | 2009-07-01 |
| Dinaciclib in Treating Patients With Stage IV Melanoma (NCT00937937) | National Cancer Institute (NCI) | 2009-07-01 |
| A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers (NCT00926640) | National Cancer Institute (NCI) | 2009-07-01 |
| Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery (NCT02007200) | National Cancer Institute (NCI) | 2009-07-01 |
| ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors (NCT00946335) | National Cancer Institute (NCI) | 2009-07-01 |
| Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab (NCT00939627) | National Cancer Institute (NCI) | 2009-07-01 |
| A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults (NCT00798265) | National Cancer Institute (NCI) | 2009-06-29 |
| Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies (NCT00923026) | National Cancer Institute (NCI) | 2009-06-15 |
| Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins (NCT01563874) | National Cancer Institute (NCI) | 2009-06-02 |
| Anal Cancer Screening Study (NCT00914537) | National Cancer Institute (NCI) | 2009-06-02 |
| Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia (NCT00933985) | National Cancer Institute (NCI) | 2009-06-01 |
| Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment (NCT00929903) | National Cancer Institute (NCI) | 2009-06-01 |
| Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma (NCT00937495) | National Cancer Institute (NCI) | 2009-06-01 |
| Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors (NCT00957905) | National Cancer Institute (NCI) | 2009-06-01 |
| Studying Different Formulations of SR13668 in Healthy Volunteers (NCT00896207) | National Cancer Institute (NCI) | 2009-06-01 |
| Vismodegib in Treating Patients With Recurrent or Refractory Medulloblastoma (NCT00939484) | National Cancer Institute (NCI) | 2009-06-01 |
| Facilitating Web-based Patient Decision Support: Decision About Medication to Lower Breast Cancer Risk (NCT00906321) | National Cancer Institute (NCI) | 2009-05-18 |
| Sun Exposure and Melanoma in Agricultural Workers (NCT00901966) | National Cancer Institute (NCI) | 2009-05-12 |
| A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer (NCT00972309) | National Cancer Institute (NCI) | 2009-05-11 |
| Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC (NCT00923364) | National Cancer Institute (NCI) | 2009-05-07 |
| S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00828139) | National Cancer Institute (NCI) | 2009-05-01 |
| Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML (NCT00895934) | National Cancer Institute (NCI) | 2009-05-01 |
| AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer (NCT00427973) | National Cancer Institute (NCI) | 2009-05-01 |
| Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma (NCT00923936) | National Cancer Institute (NCI) | 2009-04-23 |
| An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin (NCT00923104) | National Cancer Institute (NCI) | 2009-04-23 |
| Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy (NCT00892736) | National Cancer Institute (NCI) | 2009-04-20 |
| Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial (NCT00924131) | National Cancer Institute (NCI) | 2009-04-17 |
| Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases (NCT01445483) | National Cancer Institute (NCI) | 2009-04-17 |
| Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma (NCT00884741) | National Cancer Institute (NCI) | 2009-04-15 |
| A Study of Patients Receiving High-Dose Rate Brachytherapy (NCT00924027) | National Cancer Institute (NCI) | 2009-04-14 |
| Assessment of Screening Modalities for Gynecologic Cancers (NCT00879840) | National Cancer Institute (NCI) | 2009-04-09 |
| Pazopanib Hydrochloride in Treating Patients With Metastatic Melanoma That Cannot be Removed by Surgery (NCT00861913) | National Cancer Institute (NCI) | 2009-04-03 |
| Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer (NCT00803062) | National Cancer Institute (NCI) | 2009-04-01 |
| Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT00701298) | National Cancer Institute (NCI) | 2009-04-01 |
| Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment (NCT00880282) | National Cancer Institute (NCI) | 2009-04-01 |
| A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... (NCT00923481) | National Cancer Institute (NCI) | 2009-04-01 |
| GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery (NCT00878163) | National Cancer Institute (NCI) | 2009-03-31 |
| A Pilot Study to Explore Serum and Imaging Biomarkers in Patients With Spinal Cord Compression (NCT00928382) | National Cancer Institute (NCI) | 2009-03-31 |
| Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis (NCT00923832) | National Cancer Institute (NCI) | 2009-03-30 |
| Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls (NCT00867464) | National Cancer Institute (NCI) | 2009-03-30 |
| A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies (NCT00923520) | National Cancer Institute (NCI) | 2009-03-25 |
| Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer (NCT00923884) | National Cancer Institute (NCI) | 2009-03-18 |
| Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors (NCT00859937) | National Cancer Institute (NCI) | 2009-03-16 |